Dr Andrew Pierce

Lecturer (Teaching & Research)

Contact info

Location: Brambell, Room 412

Email: a.pierce@bangor.ac.uk

Current Position: Lecturer, Medical and Health Sciences

Other external Positions: Honorary Lecturer, Division of Cancer Sciences, The University of Manchester

  1. Article › Research › Peer-reviewed
  2. Generation of a conditionally immortalized myeloid progenitor cell line requiring the presence of both interleukin-3 and stem cell factor to survive and proliferate.

    C, L., CA, E., E, S., A, P., R, M. & AD, W., 3 Sept 2003, In: British Journal of Haematology. 122, 6, p. 985-995

    Research output: Contribution to journalArticlepeer-review

  3. Published

    Global effects of BCR/ABL and TEL/PDGFRbeta expression on the proteome and phosphoproteome: identification of the Rho pathway as a target of BCR/ABL.

    RD, U., DW, S., Y, L., A, P., DG, G. & AD, W., Feb 2005, In: Journal of Biological Chemistry. 280, 8, p. 6316-6326

    Research output: Contribution to journalArticlepeer-review

  4. Published

    HMG20B stabilizes association of LSD1 with GFI1 on chromatin to confer transcription repression and leukemia cell differentiation block

    Maiques-Diaz, A., Nicosia, L., Basma, N. J., Romero-Camarero, I., Camera, F., Spencer, G. J., Amaral, F. M. R., Simeoni, F., Wingelhofer, B., Williamson, A. J. K., Pierce, A., Whetton, A. D. & Somervaille, T. C. P., 28 Oct 2022, In: Oncogene. 41, 44, p. 4841-4854 14 p.

    Research output: Contribution to journalArticlepeer-review

  5. Haemopoietic growth factors and leukaemogenesis.

    Pierce, A. & AD, W., 1 May 1997, In: Biochemical Society Transactions. 25, 2, p. 366-370

    Research output: Contribution to journalArticlepeer-review

  6. Identification of curaxin as a potential new therapeutic for JAK2 V617F mutant patients

    Pearson, S., Blance, R., Yan, F., Hsieh, Y-C., Geary, B., Amaral, F. M. R., Somervaille, T. C. P., Kirschner, K., Whetton, A. D. & Pierce, A., 30 May 2023, In: PLoS ONE. 18, 5, 16 p., 0286412.

    Research output: Contribution to journalArticlepeer-review

  7. Identification of primary structural features that define the differential actions of IL-3 and GM-CSF receptors.

    CA, E., S, A., A, P. & AD, W., 1 Nov 2002, In: Blood. 100, 9, p. 3164-3174

    Research output: Contribution to journalArticlepeer-review

  8. Published

    Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia

    Alanazi, B., Munje, C. R., Rastogi, N., Williamson, A. J. K., Taylor, S., Hole, P. S., Hodges, M., Doyle, M., Baker, S., Gilkes, A. F., Knapper, S., Pierce, A., Whetton, A. D., Darley, R. L. & Tonks, A., 2020, In: Leukemia. 34, 2, p. 427-440 14 p.

    Research output: Contribution to journalArticlepeer-review

  9. Lysophospholipids synergistically promote primitive hematopoietic cell chemotaxis via a mechanism involving Vav 1.

    AD, W., Y, L., A, P., L, C. & E, S., 15 Oct 2003, In: Blood. 102, 8, p. 2798-2802

    Research output: Contribution to journalArticlepeer-review

  10. MPL W515L expression induces TGFβ secretion and leads to an increase in chemokinesis via phosphorylation of THOC5

    AD, W., NC, A., S, P., E, J., L, Z., R, B., AC, K., A, N., S, T., AJ, W. & A, P., 2016, In: Oncotarget.

    Research output: Contribution to journalArticlepeer-review

  11. Published

    Macrophage inflammatory protein-1 alpha receptors are present on cells enriched for CD34 expression from patients with chronic myeloid leukemia.

    RC, C., GS, L., PJ, O-L., A, P. & AD, W., 1 Dec 1995, In: Blood. 86, 11, p. 4270-4277

    Research output: Contribution to journalArticlepeer-review